Detalles de la búsqueda
1.
Strategies of improving adherence to lipid-lowering therapy in patients with atherosclerotic cardiovascular disease.
Curr Opin Lipidol
; 34(6): 252-258, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37594008
2.
Correction to: Recognition and Treatment of Homozygous Familial Hypercholesterolemia by Primary Care Physicians: a Survey from the National Lipid Association.
J Gen Intern Med
; 2020 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33111245
3.
Recognition and Treatment of Homozygous Familial Hypercholesterolemia by Primary Care Physicians: a Survey from the National Lipid Association.
J Gen Intern Med
; 35(7): 2225-2227, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31950403
4.
Polycystic ovary syndrome: A review of diagnosis and management, with special focus on atherosclerotic cardiovascular disease prevention.
J Clin Lipidol
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38908968
5.
Nonadherence to lipid-lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease.
Clin Cardiol
; 46(1): 13-21, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36267039
6.
Current and Emerging Therapies for Atherosclerotic Cardiovascular Disease Risk Reduction in Hypertriglyceridemia.
J Clin Med
; 12(4)2023 Feb 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36835917
7.
Impact of the COVID-19 pandemic on the management of risk factors in patients with stable atherosclerotic vascular disease.
Am J Prev Cardiol
; 14: 100499, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37193063
8.
Perceptions and Barriers on the Use of Proprotein Subtilisin/Kexin Type 9 Inhibitors in Heterozygous Familial Hypercholesterolemia (From a Survey of Primary Care Physicians and Cardiologists).
Am J Cardiol
; 152: 57-62, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34147211
9.
Cascade Screening and Treatment Initiation in Young Adults with Heterozygous Familial Hypercholesterolemia.
J Clin Med
; 10(14)2021 Jul 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34300259
10.
Awareness, diagnosis and treatment of heterozygous familial hypercholesterolemia (HeFH) - Results of a US national survey.
J Clin Lipidol
; 15(5): 682-689, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34593357
11.
Trends in PCSK9 Inhibitor Prescriptions before and after the Price Reduction in Patients with Atherosclerotic Cardiovascular Disease.
J Clin Med
; 10(17)2021 Aug 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34501275
12.
Managing cardiometabolic risk factors across a woman's lifespan: A lipidologist's perspective.
J Clin Lipidol
; 15(3): 423-430, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33836983
13.
Statin utilization and low-density lipoprotein cholesterol in statin-treated patients with atherosclerotic cardiovascular disease: Trends from a community-based health care delivery system, 2002-2016.
J Clin Lipidol
; 14(3): 305-314, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32362513
14.
JCL roundtable: Lipid treatment targets.
J Clin Lipidol
; 13(2): 223-230, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31047100
15.
The role of lipid-lowering therapy in preventing coronary heart disease in patients with type 2 diabetes.
Clin Cardiol
; 31(6): 241-8, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17847038
16.
Prevalence of emerging cardiovascular risk factors in younger individuals with a family history of premature coronary heart disease and low Framingham risk score.
Clin Cardiol
; 31(11): 542-5, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19006117
17.
Prescribing Patterns of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in Eligible Patients With Clinical Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia.
Am J Cardiol
; 121(10): 1155-1161, 2018 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29548678
18.
Direct thrombin inhibition and stroke prevention in elderly patients with atrial fibrillation: experience from the SPORTIF III and V Trials.
Stroke
; 38(11): 2965-71, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17885258
19.
Effects of increasing doses of atorvastatin on the atherogenic lipid subclasses commonly associated with hypertriglyceridemia.
Am J Cardiol
; 100(3): 445-9, 2007 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17659926
20.
The role of advanced lipid testing in clinical practice.
Prev Cardiol
; 10(4): 228-34, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17917521